Delivery Order SPE2DB22D1103-SPE2DB24FTES0
- Not listed
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with a firm fixed price of $6,715.70 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp is the prime contractor and this order is part of a larger, indefinite delivery contract (IDC) awarded by DLA, with a potential value of up...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $7,154.84 firm-fixed-price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has an ultimate completion date of August 15, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to provide a wide range of essential medical commodities to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a for-profit global pharmaceutical distribution company. The $34,753.76 firm fixed price contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The contract has a completion date of March 5, 2024. Amerisourcebergen Drug Corp also holds a larger indefinite delivery contract (IDC) with DLA, valued up to...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $14,619.00, is for the supply of STELARA 90 MG/ML syringes and has a completion date of February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, at a firm fixed price of $12,280.48. The contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division, is the prime contractor for this award. As a...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The contract is for the delivery of STELARA 90 MG/ML SYRINGE, with a potential value of $8,108.92 and a performance period through February 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, which does not have a set-aside designation. The company also holds an...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The delivery order is for the supply of STELARA 90 MG/ML SYRINGES, with a potential value of $12,998.66 and a completion date of February 13, 2024. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA,...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $6,715.70, is for the delivery of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product. The order has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA, with a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. The firm-fixed-price contract has a ceiling value of $7,735.40 and an ultimate completion date of August 26, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,402.12 firm fixed-price contract is for the supply of STELARA 90 MG/ML syringes, a specialty medication. The contract has an ultimate completion date of January 30, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB24FTES0Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty pharmaceutical product, with a firm fixed price of $7,332.74 and a completion date of February 2, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award, which is issued under an existing indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 with a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 2/1/24 |